CareTalk Podcast: "Targeting the Root Causes of Metabolic Disease w/ Bob Geho, Founder & CEO, Diasome”

Latest Updates

News

Diasome Pharmaceuticals Strengthens Leadership Team as Company Prepares for Phase 3 Development

WKYC: "A smarter insulin, better meal timing and the avocado test"

Medscape Covers Diasome's OPTI-2 Liver-Directed Insulin Data from ADA 2026

OPTI-2 Trial Results Presented at ADA on June 7th at 5pm EST